REVERAGEN BIOPHARMA

reveragen-biopharma-logo

ReveraGen BioPharma is a small clinical-stage drug development company with a focus on developing therapeutics for Duchenne muscular dystrophy. they run under a venture philanthropy model, through collaborations and partnerships with non-profit foundations and government agencies in both the US and the EU. As such, we keep the focus on stakeholders rather than stockholders.

#SimilarOrganizations #People #Website #More

REVERAGEN BIOPHARMA

Industry:
Biotechnology Government

Founded:
2008-01-01

Address:
Rockville, Maryland, United States

Country:
United States

Website Url:
http://www.reveragen.com

Total Employee:
51+

Status:
Active

Contact:
240-672-0295

Email Addresses:
[email protected]

Total Funding:
800 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

aeterna-zentaris-logo

AEterna Zentaris

AEterna Zentaris is a drug development company that specializes in oncology and endocrine therapy.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

novan-logo

Novan

Novan is a clinical-stage drug development company developing deliverable nitric oxide.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

Current Employees Featured

eric-hoffman_image

Eric Hoffman
Eric Hoffman President and CEO @ ReveraGen BioPharma
President and CEO

jesse-damsker_image

Jesse Damsker
Jesse Damsker Chief Operating Officer @ ReveraGen BioPharma
Chief Operating Officer
2010-01-01

johannes-van-den-anker_image

Johannes van den Anker
Johannes van den Anker Chief Medical Officer @ ReveraGen BioPharma
Chief Medical Officer
2017-01-01

Official Site Inspections

http://www.reveragen.com

  • Host name: 52.86.212.35.bc.googleusercontent.com
  • IP address: 35.212.86.52
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "ReveraGen BioPharma"

Home - ReveraGen BioPharma

We are a drug development company engaged in the discovery and development of proprietary therapeutic products for neuromuscular and inflammatory diseases.See details»

About Us - ReveraGen BioPharma

At ReveraGen BioPharma, we are committed to return to non-profits and their constituencies through the successful application of the venture philanthropy model.See details»

Management - ReveraGen BioPharma

Jul 29, 2016 · At ReveraGen BioPharma, we are committed to return to non-profits and their constituencies through the successful application of the venture philanthropy model. About Us; …See details»

ReveraGen BioPharma - Crunchbase Company Profile & Funding

ReveraGen BioPharma is a small clinical-stage drug development company with a focus on developing therapeutics. View contacts for ReveraGen BioPharma to access new leads and …See details»

NCATS Enables a Drug’s Path to FDA Approval for …

Mar 15, 2024 · More than a decade ago, a Rockville, MD-based company, ReveraGen BioPharma Inc., approached NCATS’ Therapeutics for Rare and Neglected Diseases (TRND) program with a compound it hoped to develop …See details»

NINDS small business funding leads to new therapy for Duchenne …

Oct 31, 2023 · ReveraGen BioPharma, a company supported by a small business grant from the National Institute of Neurological Disorders and Stroke (NINDS), has developed a new drug for …See details»

Eric Hoffman - President and CEO at ReveraGen …

He co-founded ReveraGen in 2008 together with Drs. McCall and Nagaraju, and was appointed as CEO in 2014. Dr. Hoffman splits his time between his position as Associate Dean for Research in the School of Pharmacy and …See details»

REVERAGEN BIOPHARMA, INC. - VentureRadar

ReveraGen BioPharma is a clinical-stage drug development company with a focus on developing therapeutics for Duchenne muscular dystrophy. Our lead compound, vamorolone, is a …See details»

ReveraGen BioPharma Company Profile 2024: …

Provider of clinical-stage drug development services intended to improve the lives of neuromuscular disease patients. The company specializes in steroid chemistry, pharmacodynamic biomarkers, clinical trial design, and business models for …See details»

vamorolone - ReveraGen BioPharma

Vamorolone is a potent antagonist of the mineralocorticoid receptor (MR), an activity that may be beneficial (Heier et al. 2019). All other corticosteroids are either agonists (increasing blood pressure), or show no activity for the MR.See details»

ReveraGen BioPharma - Contacts, Employees, Board Members

ReveraGen BioPharma has 3 current employee profiles, including President and CEO Eric Hoffman. ReveraGen BioPharma is a small clinical-stage drug development company with a …See details»

ReveraGen BioPharma - Products, Competitors, Financials, …

ReveraGen BioPharma is a drug development company focused on therapeutic products for neuromuscular and inflammatory diseases. The company's main product, vamorolone, is a …See details»

ReveraGen | Biotech Careers

ReveraGen is a small clinical-stage drug development company with a focus on developing therapeutics for Duchenne muscular dystrophy. We run under a venture philanthropy model, …See details»

ReveraGen BioPharma - Craft

See insights on ReveraGen BioPharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Partnerships - ReveraGen BioPharma

Multiple international stake-holder foundations have partnered with ReveraGen through grants and venture philanthropy programs.See details»

Working at ReveraGen BioPharma - Zippia

Mar 14, 2024 · Find out what it's like to work at ReveraGen BioPharma. See what kind of people work at ReveraGen BioPharma, career paths working at ReveraGen BioPharma, company …See details»

Media release - Idorsia

Nov 5, 2018 · Idorsia Ltd (SIX: IDIA) today announced that it has maintained the collaborative agreement with ReveraGen to research and co-develop vamorolone, a non-hormonal steroid …See details»

reveragen.com Reviews: Is this site a scam or legit?

Our in-depth review explains our reasoning through the use of 53 powerful factors to expose high-risk activity and see if reveragen.com is a scam. Let's look at out review of reveragen.com and …See details»

Board of Directors - ReveraGen BioPharma

Aug 1, 2016 · At ReveraGen BioPharma, we are committed to return to non-profits and their constituencies through the successful application of the venture philanthropy model. About Us; …See details»

Working at Reveragen Biopharma - Glassdoor

Glassdoor gives you an inside look at what it's like to work at Reveragen Biopharma, including salaries, reviews, office photos, and more. This is the Reveragen Biopharma company profile. …See details»

linkstock.net © 2022. All rights reserved